Immutep S.A.   Report issue

For profit Phase 1 Phase 2
Founded: Sydney Australia (2001)
Status: Acquired by Prima BioMed (2014)

Organization Overview

First Clinical Trial
2005
NCT00354263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Immutep S.A. | Immutep S.A.S | Immutep S.A.S.